ImpediMed Limited

IPDQF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$11,146-$10,072-$9,718
Dep. & Amort.$2,207$1,089$1,164
Deferred Tax$0$0$0
Stock-Based Comp.$1,418-$526-$77
Change in WC$0$562$0
Other Non-Cash$246-$2,068$4,108
Operating Cash Flow-$7,275-$11,015-$6,774
Investing Activities
PP&E Inv.$0$0-$1,672
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.-$591-$1,433-$796
Investing Cash Flow-$591-$1,433-$1,672
Financing Activities
Debt Repay.-$222$0$0
Stock Issued$0$0-$4
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0-$240-$241
Financing Cash Flow-$222-$240-$241
Forex Effect$1,149$415-$59
Net Chg. in Cash$17,693-$12,273-$8,805
Supplemental Information
Beg. Cash$0$36,905$45,710
End Cash$17,693$24,632$36,905
Free Cash Flow-$7,275-$13,881-$8,446